Antireflux Surgery Without Preoperative Esophageal Manometry
Key facts
- Who runs it
- McMaster University
- Where
- Cleveland, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Status
- Not yet recruiting
- People taking part
- 96 people, planned
- Started
- 1 Oct 2026
- Expected to end
- 30 Apr 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Preoperative workup without high-resolution esophageal manometry
- Standard preoperative workup with high-resolution esophageal manometry
- Record updated
- 10 August 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 17 criteriaShow less
Who can take part
- Age ≥ 18 years
- Documented GERD and/or hiatal hernia (Type I, II, or small Type III) confirmed on EGD and/or imaging (i.e. CT scan or upper GI study) within 12 months
- Presence of at least one guideline-based indication for antireflux surgery:; Typical GERD symptoms (heartburn and/or regurgitation) refractory to or recurrent after adequate PPI therapy; PPI-dependent GERD with patient preference for surgical management; Extra-esophageal GERD symptoms (chronic cough, laryngitis, asthma) with pathologic reflux confirmed on ambulatory pH study; Symptomatic Type II/III paraesophageal hernia (postprandial pain, early satiety, dysphagia to solids); Objective documentation of pathologic esophageal acid exposure on ambulatory reflux monitoring (24-hour pH-impedance or 48-hour Bravo pH capsule) confirming GERD diagnosis, performed within 12 months of enrollment
- Mellow-Pinkas dysphagia score = 0 at baseline (no overt dysphagia)
- Eckardt score < 1 (achalasia screening)
- Ability to provide informed consent and comply with 12-month follow-up
Who cannot take part
- Prior esophageal or gastric surgery
- BMI > 40 kg/m² (patients with severe obesity who would be candidates for bariatric surgery should be referred for metabolic/bariatric evaluation, as per the multi-society GERD guideline recommending weight-loss surgery consideration in this population)
- Prior esophageal manometry within 12 months demonstrating a major motility disorder (achalasia, absent contractility, distal esophageal spasm, hypercontractile esophagus); such patients should be managed per standard motility disorder pathways and are not candidates for this trial
- Known or clinically suspected achalasia or primary motility disorder
- Connective tissue disease with esophageal involvement (e.g., scleroderma/CREST)
- Active esophageal or gastric malignancy
- Overt dysphagia (Mellow-Pinkas ≥ 1 or Eckardt ≥ 1)
- Endoscopic stricture, mass, or luminal obstruction
- Giant paraesophageal hernia (Type IV, or Type III with >50% of stomach herniated intrathoracically)
- Pregnancy
- Participation in another interventional trial within 30 days
Where in United States
Also in 1 other country, 1 site
- Cleveland ClinicCleveland, United StatesContact: Salvador Navarrete, MDNot yet recruiting
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if people can safely skip a test called esophageal manometry before surgery for acid reflux (gastroesophageal reflux disease, or GERD) or a hiatal hernia. Manometry measures the muscles of the food pipe using a thin tube passed through the nose. The test can be uncomfortable and can delay surgery. The main questions this study aims to answer are whether people can skip manometry and still have good swallowing one year after surgery, and whether skipping the test lowers discomfort, shortens the wait for surgery, and lowers cost. To answer this, researchers will compare two groups. One group will have surgery without manometry. The other group will have manometry first, the way it is usually done. Everyone will get the same operation, a partial wrap called a Toupet fundoplication, so the study tests the value of the test and not the surgery. Participants will be placed by chance into one of the two groups, have the same standard operation, and fill out short questionnaires about their swallowing before surgery and again at 3, 6, and 12 months after surgery. Researchers want to find out if skipping manometry works just as well as the usual approach for people who do not have trouble swallowing before surgery.
The 2 groups in the trial
- No Manometry ArmTreatment being tested
Participants undergo EGD and imaging, with optional ambulatory pH testing at the discretion of the treating surgeon. High-resolution esophageal manometry is omitted before surgery. Participants proceed to standardized laparoscopic Toupet 270-degree posterior partial fundoplication with hiatal hernia repair.
Treatment: Preoperative workup without high-resolution esophageal manometry
- Standard Manometry ArmExisting treatment, for comparison
Participants undergo a standard preoperative workup, including EGD, imaging, optional ambulatory pH testing at the discretion of the treating surgeon, and high-resolution esophageal manometry before surgery. Participants proceed to standardized laparoscopic Toupet 270-degree posterior partial fundoplication with hiatal hernia repair.
Treatment: Standard preoperative workup with high-resolution esophageal manometry
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Laparoscopic Toupet Fundoplication With or Without Preoperative Esophageal Manometry in Patients With GERD and Hiatal Hernia
- Record updated
- 10 August 2026